Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0O4IN
|
||||
| Former ID |
DIB003336
|
||||
| Drug Name |
MOR-202
|
||||
| Synonyms |
Anti-CD38 antibodies, MorphoSys; HuCAL-mAb1, MorphoSys; HuCAL-mAb2, MorphoSys; HuCAL-mAb3, MorphoSys
|
||||
| Drug Type |
Antibody
|
||||
| Indication | Multiple myeloma [ICD9: 203; ICD10:C90] | Phase 1/2 | [523595] | ||
| Company |
Celgene summit; nj morphosys
|
||||
| Target and Pathway | |||||
| Target(s) | CD38 | Target Info | [551961] | ||
| NetPath Pathway | Leptin Signaling Pathway | ||||
| TCR Signaling Pathway | |||||
| PANTHER Pathway | CCKR signaling map ST | ||||
| WikiPathways | Oxytocin signaling | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.